The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion - The prognostic contribution of related molecular markers

Histopathology

Volumn 55, Issue 5, 2009, Pages 514-524

  Afonso, Julieta ^c   Santos, Lúcio Lara ^a   Amaro, Teresina ^a   Lobo, Francisco ^a   Longatto Filho, Adhemar ^b  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c Inst Sup de Saude do Alto Ave   (Portugal)

Author keywords

Blood vessel density; CD 31; Lymphatic vessel density; Urothelial carcinoma; VEGFR 3; VEGFR C

Indexed keywords

CD31 ANTIGEN; MOLECULAR MARKER; MONOCLONAL ANTIBODY D2-40; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLADDER CANCER; BLOOD VESSEL; CANCER INVASION; CONTROLLED STUDY; CYSTECTOMY; EMBOLISM; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHANGIOGENESIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 71049151160     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03425.x     Document Type: Article

References (30)

1. Kellen E, Zeegers MP, Dirx M et al. Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom. Eur. J. Cancer 2007 43 1694 1700.
2. Terakawa T, Miyake H, Muramaki M et al. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology 2008 71 123 127.
3. Black PC, Dinney CP. Bladder cancer angiogenesis and metastasis translation from murine model to clinical trial. Cancer Metastasis Rev. 2007 26 623 634.
4. Goddard JC, Sutton CD, Furness PN et al. Microvessel density at presentation predicts subsequent muscle invasion in superficial bladder cancer. Clin. Cancer Res. 2003 9 2583 2586.
5. Canoglu A, Gogus C, Beduk Y et al. Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis. Int. Urol. Nephrol. 2004 36 401 405.
6. Van der Auwera I, Cao Y, Tille JC et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br. J. Cancer 2006 95 1611 1625.
7. Honma I, Masumori N, Sato E et al. Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer analysis of role of pelvic lymph node dissection. Urology 2006 68 543 548.
8. Herrmann E, Eltze E, Bierer S et al. VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival. Anticancer Res. 2007 27 3127 3133.
9. Miyata Y, Kanda S, Ohba K et al. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D. Clin. Cancer Res. 2006 12 800 806.
10. Saban MR, Towner R, Smith N et al. Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer 2007 7 219.
11. Fernández MI, Bolenz C, Trojan L et al. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur. Urol. 2008 53 571 578.
12. Algaba F. Lymphovascular invasion as a prognostic tool for advanced bladder cancer. Curr. Opin. Urol. 2006 16 367 371.
13. Amin MB, Srigley JR, Grignon DJ et al. Urinary bladder cancer protocols and checklists. Northfield, IL : College of American Pathologists, 2005.
14. Greene FL, Page DL, Fleming ID et al. eds. AJCC cancer staging manual, 6th edn. New York : Springer Verlag, 2002 301 346.
15. Eble JN, Sauter G, Epstein JI, Sesterhenn IA eds. World Health Organization classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organ. Lyon : IARC Press, 2004 89 120.
16. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 1991 324 1 8.
17. O'Donnell RK, Feldman M, Mick R, Muschel RJ. Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discriminates between blood and lymphatic vessel invasion. J. Histochem. Cytochem. 2008 56 803 810.
18. Saito K, Kawakami S, Fujii Y et al. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J. Urol. 2007 178 2291 2296. (Pubitemid 350052165)
19. Lotan Y, Gupta A, Shariat SF et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J. Clin. Oncol. 2005 23 6533 6539.
20. Bartoletti R, Cai T, Nesi G, Sardi I, Rizzo M. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. Oncol. Rep. 2005 14 251 255.
21. Horikawa Y, Kumazawa T, Narita S et al. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy. Int. J. Clin. Oncol. 2007 12 131 136.
22. Harada K, Sakai I, Hara I et al. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy. J. Urol. 2005 12 250 255.
23. Longatto Filho A, Oliveira TG, Pinheiro C et al. How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis? World J. Surg. Oncol. 2007 11 140.
24. Ji RC. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 2006 25 677 694.
25. Zu X, Tang Z, Li Y et al. Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis. BJU Int. 2006 98 1090 1093.
26. Suzuki K, Morita T, Tokue A. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Int. J. Urol. 2005 12 152 158.
27. Mylona E, Magkou C, Gorantonakis G et al. Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder. Anticancer Res. 2006 26 3567 3571.
28. Fradet Y, Lacombe L. Can biological markers predict recurrence and progression of superficial bladder cancer? Curr. Opin. Urol. 2000 10 441 445.
29. Black PC, Dinney CP. Growth factors and receptors as prognostic markers in urothelial carcinoma. Curr. Urol. Rep. 2008 9 55 61.
30. Canter D, Guzzo T, Resnick M et al. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis. BJU Int. 2008 102 952 957.